Fibroblast Growth Factor-2 (FGF2) and Syndecan-1 (SDC1) Are Potential Biomarkers for Putative Circulating CD15+/CD30+ Cells in Poor Outcome Hodgkin Lymphoma Patients

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/1756-8722-6-62

Related search